Nearly 40% of Buy Side Firms Don’t Have Internal OTC Derivatives Pricing Capabilities, Says BNY Mellon Research

A large proportion of the buy side is falling short with regards to its internal pricing capabilities, according to a research paper by Bank of New York Mellon, with nearly 40% of the respondents to its recently conducted survey indicating that they have no in-house capabilities and are relying on counterparty valuations alone for the...

Read More